Sign Out
NINLARO is not recommended during pregnancy as it may harm the unborn baby. Breast-feeding should be stopped when taking NINLARO.
Pregnancy or breast-feeding should be avoided while being treated with NINLARO. Patients who are pregnant or breast-feeding, think they may be pregnant or are planning to have a baby should be advised before taking this medicine.
Women of childbearing potential or men who can father a child must use effective contraception during and for 90 days after treatment. Women using hormonal contraceptives should additionally use a barrier method of contraception.
As NINLARO is given in combination with lenalidomide, patients should adhere to the pregnancy prevention programme of lenalidomide because lenalidomide can be harmful to the unborn child. See the package leaflets for lenalidomide and dexamethasone for additional information on pregnancy and breast-feeding.
